Form 4: CareDx Director Receives Stock Grant

Michael Goldberg, a Director at CareDx, Inc., received a grant of 1,746 shares of common stock as part of his non-employee director compensation.

Summary

• Michael Goldberg, a Director at CareDx, Inc., received 1,746 shares of common stock on July 2, 2026.
• This stock grant is an automatic quarterly award in lieu of cash compensation for his services as a non-employee director, as per the company's Outside Director Compensation Policy.
• Following this transaction, Mr. Goldberg beneficially owns 106,438 shares of common stock directly.
• An additional 91,045 shares are held indirectly through the Cavallo Trust, where Mr. Goldberg and his spouse serve as trustees.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine compensation event for a director rather than a significant strategic or financial development for the company.

Positives

• Director compensation is being provided in the form of stock, aligning director interests with shareholders.
• The automatic quarterly grant ensures consistent compensation for the director's ongoing service.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a director's stock compensation.

Industry Context

StockSavvy.ai notes that the use of stock grants for non-employee director compensation is a common practice in the biotechnology and healthcare sectors, aiming to align executive and director interests with long-term shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: The stock grant aligns director interests with shareholders by increasing their equity stake in the company.
• Employees: No direct impact on employees is indicated by this filing.
• Creditors: No impact on creditors is indicated by this filing.

Key Dates

Keywords

CareDx, CDNA, Form 4, Director Compensation, Stock Grant, Beneficial Ownership, SEC Filing